author-400x400

Jonathan Roy

BS

Jonathan Roy Pharma Partnerships 부사장은 라이카 바이오시스템즈의 동반 진단 개발을 이끌고 있습니다. 그는 지난 10년 동안 라이카에서, 또한 GlaxoSmithKline의 동반 진단 상업 전략 책임자로서 전 세계적으로 동반 진단 개발 및 구현에 주력해 왔습니다.

Published Pieces by Jonathan Roy

암 진단에서 다중 염색의 가치
Pathologist Pathway (Knowledge Pathway, Knowledge Pathway) , 에디토리얼 (Knowledge Pathway, Knowledge Pathway)

Current technology allows tumors to be painted with multiple colors, termed multiplex staining. Multiplex staining today used in research, may also assist with cancer diagnoses clinically via: preservation of tissue, improved diagnostic accuracy, and enhanced diagnostic insight.

암 진단에서 다중 염색의 가치
Pathologist Pathway (Knowledge Pathway, Knowledge Pathway) , 에디토리얼 (Knowledge Pathway, Knowledge Pathway)

Current technology allows tumors to be painted with multiple colors, termed multiplex staining. Multiplex staining today used in research, may also assist with cancer diagnoses clinically via: preservation of tissue, improved diagnostic accuracy, and enhanced diagnostic insight.

암 진단에서 다중 염색의 가치
Pathologist Pathway (Knowledge Pathway, Knowledge Pathway) , 에디토리얼 (Knowledge Pathway, Knowledge Pathway)

Current technology allows tumors to be painted with multiple colors, termed multiplex staining. Multiplex staining today used in research, may also assist with cancer diagnoses clinically via: preservation of tissue, improved diagnostic accuracy, and enhanced diagnostic insight.